¼¼°èÀÇ ³ú³» »ê¼Ò ³óµµ ¸ð´ÏÅ͸µ ½ÃÀå
Cerebral Oximetry Monitoring
»óǰÄÚµå : 1785960
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 08¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 279 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,150,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,452,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼¼°èÀÇ ³ú³» »ê¼Ò ³óµµ ¸ð´ÏÅ͸µ ½ÃÀåÀº 2030³â±îÁö 3¾ï 2,540¸¸ ´Þ·¯¿¡ ´ÞÇÒ Àü¸Á

2024³â¿¡ 2¾ï 2,670¸¸ ´Þ·¯·Î ÃßÁ¤µÇ´Â ¼¼°èÀÇ ³ú³» »ê¼Ò ³óµµ ¸ð´ÏÅ͸µ ½ÃÀåÀº 2024-2030³âÀÇ ºÐ¼® ±â°£¿¡ CAGR 6.2%·Î ¼ºÀåÇϸç, 2030³â¿¡´Â 3¾ï 2,540¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ ¸®Æ÷Æ®¿¡¼­ ºÐ¼®ÇÑ ºÎ¹®ÀÇ ÇϳªÀÎ ½ÉÀå¿Ü°ú ¾ÖÇø®ÄÉÀ̼ÇÀº CAGR 7.0%¸¦ ±â·ÏÇϸç, ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 2¾ï 480¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. Ç÷°ü ¿Ü°ú ¾ÖÇø®ÄÉÀÌ¼Ç ºÎ¹®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£¿¡ CAGR 5.5%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 6,180¸¸ ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR 9.9%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ ³ú³» »ê¼Ò ³óµµ ¸ð´ÏÅ͸µ ½ÃÀåÀº 2024³â¿¡ 6,180¸¸ ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ÀÇ °æÁ¦´ë±¹ÀÎ Áß±¹Àº ºÐ¼® ±â°£ 2024-2030³â¿¡ CAGR 9.9%·Î ÃßÀÌÇϸç, 2030³â¿¡´Â ¿¹Ãø ½ÃÀå ±Ô¸ð 6,710¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ±âŸ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£ Áß CAGRÀº °¢°¢ 3.0%¿Í 6.1%·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 4.1%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°èÀÇ ³ú³» »ê¼Ò ³óµµ ¸ð´ÏÅ͸µ ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

³ú »ê¼Ò ³óµµ ¸ð´ÏÅ͸µÀÌ È¯ÀÚÀÇ ¿¹Èĸ¦ ¾î¶»°Ô °³¼±ÇÒ ¼ö Àִ°¡?

³ú »ê¼Ò ³óµµ ¸ð´ÏÅ͸µÀº ³ú »ê¼Ò Æ÷È­µµ¸¦ ½Ç½Ã°£À¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ½Å°æ ¸ð´ÏÅ͸µ ºÐ¾ß¿¡ Çõ¸íÀ» ÀÏÀ¸Å°°í ÀÖ½À´Ï´Ù. ÀÌ ±â¼úÀº ƯÈ÷ ½ÉÀå ¼ö¼ú, ½Å°æ¿Ü°ú¼ö¼ú, ÁßȯÀÚ½Ç µî À§Çèµµ°¡ ³ôÀº ¼ö¼ú¿¡¼­ ³ú Àú»ê¼ÒÁõÀ» ¿¹¹æÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÕ´Ï´Ù. ³ú »ê¼Ò ³óµµ°è´Â Áö¼ÓÀûÀÎ ¸ð´ÏÅ͸µÀ» ÅëÇØ ÀÓ»óÀǰ¡ Àú»ê¼ÒÁõÀÇ Â¡Èĸ¦ Á¶±â¿¡ ¹ß°ßÇϰí Àû½Ã¿¡ °³ÀÔÇÏ¿© ½Å°æÇÐÀû ÇÕº´ÁõÀÇ À§ÇèÀ» ÁÙÀÏ ¼ö ÀÖµµ·Ï µ½½À´Ï´Ù. ºñħ½ÀÀû ¸ð´ÏÅ͸µ ±â¼úÀÇ Ã¤ÅÃÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ³ú »ê¼Ò ÃøÁ¤ ÀåÄ¡ ¼ö¿ä°¡ ´õ¿í Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÌ ÀåÄ¡´Â ±ÙÀû¿Ü¼± ºÐ±¤¹ý(NIRS) ±â¼úÀ» Ȱ¿ëÇÏ¿© ħ½ÀÀû ½Ã¼ú ¾øÀ̵µ ½Ç½Ã°£ »ê¼ÒÈ­ »óŸ¦ Á¦°øÇÕ´Ï´Ù. ÀÇ·á ¼­ºñ½º ÇÁ·Î¹ÙÀÌ´õ°¡ ȯÀÚÀÇ ¾ÈÀü°ú ÀÓ»ó °á°ú °³¼±¿¡ ÁßÁ¡À» µÎ¸é¼­ ³ú »ê¼Ò ³óµµ ¸ð´ÏÅ͸µ¿¡ ´ëÇÑ ¼ö¿ä°¡ Å©°Ô Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

³ú »ê¼Ò ³óµµ ¸ð´ÏÅ͸µ¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÏ´Â ÀÌÀ¯´Â ¹«¾ùÀΰ¡?

½Å°æÁúȯÀÇ À¯º´·ü Áõ°¡¿Í ³ú ¸ð´ÏÅ͸µÀÌ ÇÊ¿äÇÑ ¼ö¼ú °Ç¼ö Áõ°¡°¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÏ´Â ÁÖ¿ä ¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. º¹ÀâÇÑ ½ÉÀå¼ö¼úÀ̳ª ½Å°æ¿Ü°ú¼ö¼úÀ» ¹Þ´Â ȯÀÚ°¡ Áõ°¡ÇÔ¿¡ µû¶ó ¼ö¼ú ÈÄ ÇÕº´ÁõÀ» ¿¹¹æÇϱâ À§ÇÑ Áö¼ÓÀûÀÎ ¸ð´ÏÅ͸µÀÌ ÇÊ¿äÇÏ°Ô µÇ¾ú½À´Ï´Ù. ÁßȯÀÚ½Ç(ICU)°ú ½Å»ý¾Æ ÁßȯÀÚ½Ç(NICU)ÀÇ È®Àåµµ ÁßȯÀÚ °ü¸®¿¡¼­ ³ú »ê¼Ò ÃøÁ¤±âÀÇ »ç¿ë Áõ°¡¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ Àü ¼¼°è¿¡¼­ °í·ÉÈ­·Î ÀÎÇØ ³úÁ¹Áß, Ä¡¸Å ¹× ±âŸ ½Å°æÁúȯÀÇ À§Çè¿¡ óÇÑ »ç¶÷µéÀÇ ¼ö°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÇ·á ½Ã½ºÅÛÀº Á¶±â ¹ß°ß ¹× °³ÀÔ Àü·«À» ¿ì¼±½ÃÇϰí ÀÖÀ¸¸ç, ³ú »ê¼Ò ³óµµ ¸ð´ÏÅ͸µÀÇ Ã¤ÅÃÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ¸¶Ãë ¹× ¼ö¼ú ÀüÈÄ ÀÇ·á¿¡ ÀÌ·¯ÇÑ Àåºñ¸¦ ÅëÇÕÇÏ¿© ÀÎÁö Àå¾Ö ¹× ½Å°æÇÐÀû ºÎÀÛ¿ëÀÇ À§ÇèÀ» ÃÖ¼ÒÈ­ÇÏ°í º¸´Ù ¾ÈÀüÇÑ ¼ö¼úÀ» º¸ÀåÇϱâ À§ÇØ ÀÌ·¯ÇÑ ÀåºñÀÇ ÅëÇÕÀÌ °¡¼ÓÈ­µÇ°í ÀÖ½À´Ï´Ù.

³ú »ê¼Ò ³óµµ ¸ð´ÏÅ͸µÀÇ Ã¤ÅÃÀ» ÁÖµµÇÏ´Â Áö¿ªÀº?

ºÏ¹Ì°¡ ³ú »ê¼Ò ³óµµ ¸ð´ÏÅ͸µ ½ÃÀåÀ» µ¶Á¡Çϰí ÀÖ´Â °ÍÀº ÷´Ü ÀÇ·á ÀÎÇÁ¶ó, ½Å°æ ¸ð´ÏÅ͸µ ÀåÄ¡ÀÇ ±¤¹üÀ§ÇÑ Ã¤ÅÃ, °­·ÂÇÑ ±ÔÁ¦ Áö¿øÀ¸·Î ÀÎÇÑ °ÍÀÔ´Ï´Ù. ¹Ì±¹°ú ij³ª´ÙÀÇ ÁÖ¿ä ½ÃÀå ±â¾÷ÀÇ Á¸Àç¿Í Áö¼ÓÀûÀÎ ±â¼ú ¹ßÀüÀº ÀÌ ºÐ¾ß¿¡¼­ ÀÌ Áö¿ªÀÇ ¸®´õ½Ê¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ½ÉÇ÷°ü Áúȯ°ú ½Å°æÁúȯÀÇ ³ôÀº À¯º´·üµµ ½ÃÀå ¼ö¿ä¸¦ ´õ¿í °­È­½Ã۰í ÀÖ½À´Ï´Ù. µ¶ÀÏ, ¿µ±¹, ÇÁ¶û½º µîÀÇ ±¹°¡µéÀÌ Ã·´Ü ȯÀÚ ¸ð´ÏÅ͸µ ¼Ö·ç¼Ç¿¡ ÅõÀÚÇϰí ÀÖ½À´Ï´Ù. ȯÀÚÀÇ ¾ÈÀü°ú Ä¡·áÀÇ ÁúÀ» Áß½ÃÇÏ´Â ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©°¡ º´¿ø°ú ¼ö¼ú¼¾ÅÍ Àüü¿¡¼­ ³ú »ê¼Ò ÃøÁ¤±â äÅÃÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ÇÑÆí, ¾Æ½Ã¾ÆÅÂÆò¾çÀº ÀÇ·á ÅõÀÚ Áõ°¡, ½Å°æ ¸ð´ÏÅ͸µ ±â¼ú¿¡ ´ëÇÑ ÀÎ½Ä Áõ°¡, Áß±¹, ÀϺ», Àεµ¿Í °°Àº ±¹°¡ÀÇ ½Å°æÁúȯ ¹× ½ÉÇ÷°ü ÁúȯÀÇ ºÎ´ã Áõ°¡·Î ÀÎÇØ ½ÃÀåÀÌ ºü¸£°Ô ¼ºÀåÇϰí ÀÖ½À´Ï´Ù.

½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÏ´Â ÁÖ¿ä ¿äÀÎÀº ¹«¾ùÀΰ¡?

³ú »ê¼Ò ³óµµ ¸ð´ÏÅ͸µ ½ÃÀåÀÇ ¼ºÀåÀº ºñħ½ÀÀû ¸ð´ÏÅ͸µ ±â¼úÀÇ ¹ßÀü, ³ú ¸ð´ÏÅ͸µÀÌ ÇÊ¿äÇÑ ¼ö¼ú Áõ°¡, ȯÀÚÀÇ ¾ÈÀü¿¡ ´ëÇÑ ÀÎ½Ä Áõ°¡ µî ¿©·¯ °¡Áö ¿äÀο¡ ÀÇÇØ ÀÌ·ç¾îÁý´Ï´Ù. ÀΰøÁö´É(AI)°ú ¸Ó½Å·¯´×À» ³ú »ê¼Ò ÃøÁ¤ Àåºñ¿¡ ÅëÇÕÇÏ¿© ½Ç½Ã°£ µ¥ÀÌÅÍ ºÐ¼®À» °­È­Çϰí, º¸´Ù Á¤È®ÇÏ°í ¿¹Ãø °¡´ÉÇÑ Áø´ÜÀ» °¡´ÉÇÏ°Ô ÇÕ´Ï´Ù. ¶ÇÇÑ °¡Ä¡ ±â¹Ý ÀÇ·á·ÎÀÇ Àüȯ°ú º´¿ø³» ÇÕº´Áõ °¨¼Ò¿¡ ´ëÇÑ °­Á¶´Â º´¿ø°ú ¼ö¼ú¼¾ÅͰ¡ ³ú ¸ð´ÏÅ͸µ ¼Ö·ç¼Ç¿¡ ´ëÇÑ ÅõÀÚ¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¿ø°ÝÀÇ·á¿Í ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µÀÇ È®´ë´Â ƯÈ÷ ¼­ºñ½º°¡ ºÎÁ·ÇÑ Áö¿ª¿¡¼­ ³ú »ê¼Ò ÃøÁ¤¿¡ ´ëÇÑ ±¤¹üÀ§ÇÑ Á¢±ÙÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¿¬±¸¸¦ ÅëÇØ ³ú »ê¼ÒÃøÁ¤±âÀÇ ÀÓ»óÀû À¯¿ë¼ºÀÌ °è¼Ó °ËÁõµÊ¿¡ µû¶ó ±× º¸±ÞÀÌ °¡¼ÓÈ­µÇ°í Çö´ë ÀÇ·á ½Ã½ºÅÛ¿¡ Áß¿äÇÑ ÅøÀÌ µÉ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

ºÎ¹®

¿ëµµ(½ÉÀå¿Ü°ú ¿ëµµ, Ç÷°ü ¿Ü°ú ¿ëµµ, ±âŸ ¿ëµµ), ÃÖÁ¾ ¿ëµµ(º´¿ø¡¤Å¬¸®´Ð ÃÖÁ¾ ¿ëµµ, ¿Ü·¡ ¼ö¼ú ¼¾ÅÍ ÃÖÁ¾ ¿ëµµ, ±âŸ ÃÖÁ¾ ¿ëµµ)

Á¶»ç ´ë»ó ±â¾÷ÀÇ ¿¹

AI ÅëÇÕ

Global Industry Analysts´Â À¯È¿ÇÑ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AI Åø¿¡ ÀÇÇØ ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ º¯ÇõÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â LLM³ª ¾÷°è °íÀ¯ SLM¸¦ Á¶È¸ÇÏ´Â ÀϹÝÀûÀÎ ±Ô¹ü¿¡ µû¸£´Â ´ë½Å¿¡, ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ¹æ´ëÇÑ ¾ç ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî, Àü ¼¼°è Àü¹®°¡·ÎºÎÅÍ Å¥·¹ÀÌÆ®µÈ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»ç ¼ÒÀçÁö, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±âÁØÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇß½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¼öÀÔ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº Ç϶ô, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû, °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå °³¿ä

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Cerebral Oximetry Monitoring Market to Reach US$325.4 Million by 2030

The global market for Cerebral Oximetry Monitoring estimated at US$226.7 Million in the year 2024, is expected to reach US$325.4 Million by 2030, growing at a CAGR of 6.2% over the analysis period 2024-2030. Cardiac Surgery Application, one of the segments analyzed in the report, is expected to record a 7.0% CAGR and reach US$204.8 Million by the end of the analysis period. Growth in the Vascular Surgery Application segment is estimated at 5.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$61.8 Million While China is Forecast to Grow at 9.9% CAGR

The Cerebral Oximetry Monitoring market in the U.S. is estimated at US$61.8 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$67.1 Million by the year 2030 trailing a CAGR of 9.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.0% and 6.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.1% CAGR.

Global Cerebral Oximetry Monitoring Market - Key Trends & Drivers Summarized

How Is Cerebral Oximetry Monitoring Enhancing Patient Outcomes?

Cerebral oximetry monitoring is revolutionizing the field of neuromonitoring by providing real-time insights into cerebral oxygen saturation levels. This technology is crucial in preventing cerebral hypoxia, particularly in high-risk surgical procedures such as cardiac surgery, neurosurgery, and critical care settings. By enabling continuous monitoring, cerebral oximeters help clinicians detect early signs of hypoxia, allowing for timely interventions and reducing the risk of neurological complications. The increasing adoption of non-invasive monitoring techniques has further propelled the demand for cerebral oximetry devices. These devices utilize near-infrared spectroscopy (NIRS) technology to provide real-time oxygenation status without requiring invasive procedures. As healthcare providers focus on patient safety and improved clinical outcomes, the demand for cerebral oximetry monitoring is expected to grow significantly.

Why Is the Demand for Cerebral Oximetry Monitoring Rising?

The growing prevalence of neurological disorders and the rising number of surgeries requiring cerebral monitoring are key factors driving market growth. An increasing number of patients undergoing complex cardiac and neurosurgical procedures necessitates continuous monitoring to prevent postoperative complications. The expansion of intensive care units (ICUs) and neonatal intensive care units (NICUs) is also contributing to the increasing use of cerebral oximetry in critical care management. Additionally, the aging global population is leading to a rise in the number of individuals at risk of stroke, dementia, and other neurological conditions. Healthcare systems are prioritizing early detection and intervention strategies, further fueling the adoption of cerebral oximetry monitoring. The integration of these devices into anesthesia and perioperative care is also gaining momentum, ensuring safer surgical procedures with minimized risks of cognitive impairment and adverse neurological outcomes.

Which Regions Are Leading in Cerebral Oximetry Monitoring Adoption?

North America dominates the cerebral oximetry monitoring market due to its advanced healthcare infrastructure, widespread adoption of neuromonitoring devices, and strong regulatory support. The presence of key market players and ongoing technological advancements in the United States and Canada have contributed to the region's leadership in this sector. The high prevalence of cardiovascular and neurological diseases further strengthens market demand. Europe follows closely, with countries like Germany, the UK, and France investing in advanced patient monitoring solutions. Regulatory frameworks that emphasize patient safety and quality of care are driving the adoption of cerebral oximetry devices across hospitals and surgical centers. Meanwhile, the Asia-Pacific region is experiencing rapid market expansion due to increasing healthcare investments, growing awareness of neuromonitoring technologies, and the rising burden of neurological and cardiovascular conditions in countries like China, Japan, and India.

What Are the Key Factors Driving Market Growth?

The growth in the cerebral oximetry monitoring market is driven by several factors, including advancements in non-invasive monitoring technologies, increasing surgical procedures requiring cerebral monitoring, and heightened awareness of patient safety. The integration of artificial intelligence (AI) and machine learning into cerebral oximetry devices is enhancing real-time data analysis, allowing for more accurate and predictive diagnostics. Additionally, the shift towards value-based healthcare and the emphasis on reducing hospital-acquired complications are prompting hospitals and surgical centers to invest in cerebral monitoring solutions. The expansion of telemedicine and remote patient monitoring is also facilitating broader access to cerebral oximetry, especially in underserved regions. As research continues to validate the clinical benefits of cerebral oximetry monitoring, its adoption is expected to accelerate, making it a critical tool for modern healthcare systems.

SCOPE OF STUDY:

The report analyzes the Cerebral Oximetry Monitoring market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Application (Cardiac Surgery Application, Vascular Surgery Application, Other Applications); End-Use (Hospitals and Clinics End-Use, Ambulatory Surgical Centers End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â